Recent Patents on Anti-Infective Drug Discovery
Title:Invited Editorial: Malaria by Plasmodium knowlesi, A Zoonosis Transmitted by Vectors
Volume: 10 Issue: 1
Author(s): Jorge E. Machado-Alba
Affiliation:
Export Options
About this article
Cite this article as:
Machado-Alba E. Jorge, Invited Editorial: Malaria by Plasmodium knowlesi, A Zoonosis Transmitted by Vectors, Recent Patents on Anti-Infective Drug Discovery 2015; 10 (1) . https://dx.doi.org/10.2174/1574891X10666150408155455
DOI https://dx.doi.org/10.2174/1574891X10666150408155455 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
22
1
Related Articles
-
JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms
Current Medicinal Chemistry Is There Any Scientific Basis of Hawan to be Used in the Alzheimer’s Disease Prevention/Cure?
Current Traditional Medicine Role of the Sympathetic Nervous Activity in Hypertension-Update in 2013
Current Hypertension Reviews NMDA Receptor Antagonists as Antidepressant and Antidementia Drugs: Recent Developments and Future Prospects
Current Medicinal Chemistry - Central Nervous System Agents Familial Hypercholesterolemia: Etiology, Diagnosis and New Treatment Options
Current Pharmaceutical Design Hydrolases in Organic Chemistry. Recent Achievements in the Synthesis of Pharmaceuticals
Current Organic Chemistry Endothelial Dysfunction in Metabolic Diseases: Role of Oxidation and Possible Therapeutic Employment of N-acetylcysteine
Current Medicinal Chemistry Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents
Current Cancer Drug Targets Magnetic Digital Microfluidics for Point-of-Care Testing: Where Are We Now?
Current Medicinal Chemistry Discovery and Advancement of Farnesyl Transferase Inhibitors as Potential Anticancer Therapeutic Agents: SCH 66336 a Case Study
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Class IV Antiarrhythmic Agents: New Compounds Using an Old Strategy
Current Pharmaceutical Design The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders I: Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
Current Genomics microRNAs: Innovative Targets for Cerebral Ischemia and Stroke
Current Drug Targets Current Treatment Concepts of Philadelphia-Negative MPN
Current Cancer Drug Targets Inotropic and Vasoactive Drugs in Pediatric ICU
Current Drug Targets Pharmacokinetics of Selegiline in a Rabbit Model
Letters in Drug Design & Discovery Anesthetic Considerations for Electroconvulsive Therapy-Especially Hemodynamic and Respiratory Management
Current Psychiatry Reviews Compendious Review on Bioactive Constituents and Pharmacotherapeutic Profile of Heliotropium indicum Linn
The Natural Products Journal Introduction to the Special Issue “Pharmacotherapies for the Treatment of Alcohol Abuse and Dependence” and a Summary of Patents Targeting other Neurotransmitter Systems
Recent Patents on CNS Drug Discovery (Discontinued)